WGS logo

WGS GeneDx Holdings Corp.

NASDAQ Global Market · Medical - Diagnostics & Research · Healthcare

$45.46
-3.78 (-7.68%)

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and canc…

Market Cap: $1.36Bwww.genedx.com

Price

No data yet.

Social Signal Score

59
5d
—
30d
63
4 mentions
—
60d
57
7 mentions
—
90d
57
7 mentions
—
news: 7

Analyst Ratings

11 analysts
Buyconsensus
Strong Buy 0Buy 10Hold 1Sell 0Strong Sell 0
Avg price target$80.25+76.5%
Low $63Median $84High $90
Current Consensus

Revenue

$123.10M+218.85%
$36.17M$65.15M$94.12M$123.10M
Sep 2020Sep 2026

Analyst Estimates

FY2025
$1.36
$1.31–$1.43
4 analysts
FY2026
$0.42-69% YoY
$0.40–$0.44
3 analysts
FY2027
$1.19+184% YoY
$1.14–$1.25
4 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Katherine A. Stueland
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
1,300
Beta
1.99
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
-0.28
www.genedx.com